General Info
David Thompson is a Co-Founder, General Partner, and Chief Financial Officer at 415 Capital with over 35 years of experience in corporate management, audit, and finance. His investment focus is on the medical technology sector, with investments in over 20 medical technology companies. David co-founded and managed European medical device distribution companies. He has a degree in Accountancy from the University of Birmingham and is a member of the Institute of Chartered Accountants in England & Wales.
Location:
Country: United Kingdom of Great Britain and Northern Ireland
Industries:
Investment Regions: EU, NA
Investment Stages: pre-seed, seed
Website: https://www.415capital.com/team.html
angel-individual
EU, NA
Want to start building warm intros with this investor?
🤖 AI Activity Report
Status: not-found
AI Reasoning: Searches of 415 Capital team page and Google queries did not return any verifiable press releases or news articles showing recent investments by David Thompson. No investment dates or portfolio company announcements were found to determine recency. Without clear evidence of an investee and date, default to not-found.
Angel activity thresholds:
Low Activity – Only known angel investments more than 12 months ago.
Active – Known angel investments between the last 12 and 6 months.
Very Active – Known angel investments in the last 6 months.
Investor Contact
Team Members
Name
Role
Email
LinkedIn
…
…
…
…
…
Investment Regions Map
loading map…
Similar Investors
Other similar investors:
Latest on X (Twitter)
Access all contact details of David Thompson

Gain instant access to partner names, verified emails, LinkedIn profiles, and more—all in one place. Dive into their portfolio founders and their LinkedIn information, so you can quickly start your outreach and look for warm intros.
Add custom tags to your investor cards. Label them by investment stage, industry focus, interest level, or any other criteria you want to stay organized.
Trusted by Founders like You
Find your matching investors using AI
